Cervical Ripening: A Comparison Between Intravaginal Misoprostol Tablet and Intracervical Foley's Catheter and Subsequent Induction of Labor, Safety and Efficacy in Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria.

NCT ID: NCT02574338

Last Updated: 2019-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2018-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the effectiveness and safety of Foley's catheter and misoprostol in cervical ripening.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized clinical study which will be made up of two arms or groups. The first arm or group - 1 will have cervical ripening with intracervical extraamniotic Foley's catheter while group - 2 will have cervical ripening with intravaginal misoprostol. The parturients will be randomly selected by simple lottery and recruited into the two arms of the study. Each parturient will pick by simple lucky dip from a pool of folded papers with inscription group 1 or group 2 in a bag in a double blinded manner and will be recruited into the group picked among the two arms of the study. The Bishop's score of the cervix will be accurately determined and documented before cervical ripening. Bishop's score of ≥6 will be considered ripe. Oxytocin will be used for induction or augmentation of labor as required.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Ripening and Induction of Labor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group - 1 Foley's Catheter

will have cervical ripening with intracervical extraamniotic Foley's catheter for 24 hours

Group Type ACTIVE_COMPARATOR

Foley's Catheter

Intervention Type DEVICE

intracervical extraamniotic Foley's catheter

Group - 2 Prostaglandin E1 Analogue

will have cervical ripening with intravaginal misoprostol inserted into the posterior fornix every six hours to a maximum of four doses (24 hours)

Group Type ACTIVE_COMPARATOR

prostaglandin E1 analogue

Intervention Type DRUG

intravaginal misoprostol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Foley's Catheter

intracervical extraamniotic Foley's catheter

Intervention Type DEVICE

prostaglandin E1 analogue

intravaginal misoprostol

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Misoprostol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parturients who gave consent
* has low bishop score (≤5)
* term singleton cephalic presenting fetus
* intact membranes
* no contraindication to vaginal delivery

Exclusion Criteria

* those who refused consent
* preterm delivery
* vaginal infection
* non-cephalic presentation
* multiple gestation
* low lying placenta/previa,
* vaginal bleeding,
* previous cesarean section
* rupture of membranes
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nwali Matthew Igwe

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nwali Matthew Igwe

Dr

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Federal Teaching Hospital, Abakaliki

Abakaliki, Ebonyi State, Nigeria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nigeria

References

Explore related publications, articles, or registry entries linked to this study.

de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4.

Reference Type DERIVED
PMID: 36996264 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSFC-2015-CT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hysteroscopy and Misoprostol Project
NCT00363389 COMPLETED PHASE3
Misoprostol in Missed Abortion
NCT06818903 NOT_YET_RECRUITING